Katey Owen
Förmögenhet: 2 M $ per 2026-06-30
Förmögenhet: 2 M $ per 2026-06-30
Katey Owen is currently an Independent Director at Adaptive Biotechnologies Corp.
since 2021 and Director-Vaccine Development at Gates Foundation Trust since 2022.
Formerly, Dr. Owen was Senior Director at Merck & Co., Inc. Education includes undergraduate and doctorate degrees from Purdue University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-01 | 72 629 ( 0,05 % ) | 2 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Direktör/Styrelseledamot | 2021-03-17 |
Gates Foundation Trust
Gates Foundation Trust Financial ConglomeratesFinance Foundation | Företagsledare/Principal | 2013-08-01 |
| Företag | Position | Slut |
|---|---|---|
| MERCK & CO., INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Gates Foundation Trust
Gates Foundation Trust Financial ConglomeratesFinance Foundation | Finance |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån